• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION 213, LLC 0113 CHLORAPREP ONE-STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION 213, LLC 0113 CHLORAPREP ONE-STEP; 2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL Back to Search Results
Catalog Number 260400NS
Device Problems Labelling, Instructions for Use or Training Problem (1318); Device Markings/Labelling Problem (2911)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/10/2021
Event Type  malfunction  
Manufacturer Narrative
(b)(6) initial emdr submission.A follow up emdr will be submitted if additional information becomes available.(b)(4).
 
Event Description
It was reported that the label print is misaligned and the impression is inadequate.Per complaint details: nonconformance description: during packaging of order (b)(4), manufacturing department reported to found 35 pieces of material u-45703-002 batch 13p20h0445 with inadequate impression of 'information of use' on the lidstock of the chloraprep.(some chlorapreps have illegible text).
 
Manufacturer Narrative
A photo was provided for evaluation.Visual examination of the photo shows the root cause of the condition appears to be that the lidding (tip web) was out of registration with respect to the rest of the package.This verified the reported issue.A device history review did not show that any in-process non-conformances, or that process adjustments were required during the manufacturing of this lot.The lot was released by passing all qa inspections.Trend analysis shows that no other incidents have been reported for pn 260400ns lot 0191859.This appears to have been an isolated occurrence.An awareness training was performed involving all 3ml packaging associated and to the qa technicians.No further action is planned at this time.This failure mode will continue to be tracked and trended.H3 other text: see narrative below.
 
Event Description
It was reported that the label print is misaligned and the impression is inadequate.Per attached complaint details: nonconformance description: during packaging of order 3012711, manufacturing department reported to found 35 pieces of material u-45703-002, batch 13p20h0445 with inadequate impression of 'information of use' on the lidstock of the chloraprep.(some chlorapreps have ilegible text).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CHLORAPREP ONE-STEP
Type of Device
2% W/V CHLORHEXIDINE GLUCONATE/70% V/V ISOPROPYL ALCOHOL
Manufacturer (Section D)
CAREFUSION 213, LLC 0113
1550 northwestern dr
el paso TX 79912
MDR Report Key11628200
MDR Text Key247780992
Report Number3004932373-2021-00178
Device Sequence Number1
Product Code KXF
Combination Product (y/n)Y
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,other
Type of Report Initial,Followup
Report Date 06/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date06/30/2023
Device Catalogue Number260400NS
Device Lot Number0191859
Initial Date Manufacturer Received 03/11/2021
Initial Date FDA Received04/07/2021
Supplement Dates Manufacturer Received06/21/2021
Supplement Dates FDA Received06/28/2021
Patient Sequence Number1
Patient Outcome(s) Other;
-
-